RejuvaKnee meniscal repair implant
Category: Mechanical/Materials
Developers: Regenity Biosciences
Product Description:RejuvaKnee is a minimally invasive collagen-based meniscal implant indicated for use in the reinforcement and repair of soft tissue injuries of the meniscus. It is a purified intact bovine meniscus implant that is biocompatible and bioresorbable. RejuvaKnee acts as a scaffold and allows for a more complete recovery by facilitating the regeneration of the native medial meniscal tissue instead of cutting or replacing it. By harnessing regenerative medicine, this offers a solution that can advance what is possible with healing knee injuries. This approach prioritizes patient well-being and has the potential to repair meniscal injuries, helping to slow or prevent future joint degeneration. By reducing meniscal deterioration, RejuvaKnee may also decrease the need for follow-up surgeries and delay or even eliminate the necessity for total knee replacements. RejuvaKnee is intended for use in surgical procedures for the reinforcement and repair of soft tissue injuries of the medial meniscus. It reinforces soft tissue and provides a resorbable scaffold that is replaced by the patient’s own soft tissue. Many complex meniscus tears are currently treated with a partial resection for symptomatic relief, but with the significant risk of increased contact pressures and more rapid progression of arthritis, RejuvaKnee provides a scaffold for the patient to regenerate their own meniscal tissue for these defects. Favorable incorporation of the scaffold can not only offer symptomatic relief but also has the potential to reduce osteoarthritis and quality of life over time for patients.
Developers: Regenity Biosciences
Product Description:RejuvaKnee is a minimally invasive collagen-based meniscal implant indicated for use in the reinforcement and repair of soft tissue injuries of the meniscus. It is a purified intact bovine meniscus implant that is biocompatible and bioresorbable. RejuvaKnee acts as a scaffold and allows for a more complete recovery by facilitating the regeneration of the native medial meniscal tissue instead of cutting or replacing it. By harnessing regenerative medicine, this offers a solution that can advance what is possible with healing knee injuries. This approach prioritizes patient well-being and has the potential to repair meniscal injuries, helping to slow or prevent future joint degeneration. By reducing meniscal deterioration, RejuvaKnee may also decrease the need for follow-up surgeries and delay or even eliminate the necessity for total knee replacements. RejuvaKnee is intended for use in surgical procedures for the reinforcement and repair of soft tissue injuries of the medial meniscus. It reinforces soft tissue and provides a resorbable scaffold that is replaced by the patient’s own soft tissue. Many complex meniscus tears are currently treated with a partial resection for symptomatic relief, but with the significant risk of increased contact pressures and more rapid progression of arthritis, RejuvaKnee provides a scaffold for the patient to regenerate their own meniscal tissue for these defects. Favorable incorporation of the scaffold can not only offer symptomatic relief but also has the potential to reduce osteoarthritis and quality of life over time for patients.
